Article Details

After Investing, GSK to Buy Out Celiac Drug Developer Sitari Pharma

Retrieved on: 2019-09-11 02:45:00

Tags for this article:

Click the tags to see associated articles and topics

After Investing, GSK to Buy Out Celiac Drug Developer Sitari Pharma. View article details on hiswai:

Excerpt

<div>GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm <b>Avalon Ventures</b>.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up